Orit Sagi-Assif Selected Research

GDPmannose 4,6-dehydratase

9/2004	Tumor-microenvironment interactions: the fucose-generating FX enzyme controls adhesive properties of colorectal cancer cells.
4/2002	Human Ly-6 antigen E48 (Ly-6D) regulates important interaction parameters between endothelial cells and head-and-neck squamous carcinoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Orit Sagi-Assif Research Topics

Disease

19	Neoplasms (Cancer) 01/2021 - 04/2002
18	Neoplasm Metastasis (Metastasis) 01/2020 - 04/2002
15	Melanoma (Melanoma, Malignant) 01/2021 - 05/2010
5	Neuroblastoma 01/2017 - 03/2004
3	Colorectal Neoplasms (Colorectal Cancer) 10/2008 - 09/2004
3	Leukemia 10/2003 - 01/2003
2	Squamous Cell Carcinoma of Head and Neck 09/2004 - 04/2002
2	Adenocarcinoma 03/2004 - 10/2003
2	Breast Neoplasms (Breast Cancer) 03/2004 - 10/2003
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2003 - 01/2003
1	Virus Diseases (Viral Diseases) 01/2022
1	Lymphatic Metastasis 01/2020
1	Brain Neoplasms (Brain Tumor) 01/2020
1	Reperfusion Injury 01/2014
1	Neoplasm Micrometastasis 09/2012
1	Starvation 04/2006
1	Myeloid Leukemia (Leukemia, Myelocytic) 10/2003
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2003
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2002

Drug/Important Bio-Agent (IBA)

11	LigandsIBA 05/2017 - 04/2002
6	ChemokinesIBA 05/2010 - 04/2002
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2002
5	Biomarkers (Surrogate Marker)IBA 01/2017 - 08/2008
4	Chemokine ReceptorsIBA 05/2017 - 03/2004
4	SelectinsIBA 10/2008 - 04/2002
3	Pharmaceutical PreparationsIBA 01/2021 - 05/2015
3	E-SelectinIBA 10/2008 - 04/2002
3	Dual Specificity Phosphatase 1IBA 10/2003 - 01/2003
2	AngiopoietinsIBA 09/2017 - 09/2012
2	Small Interfering RNA (siRNA)IBA 10/2015 - 09/2004
2	Fibronectins (Fibronectin)IBA 05/2015 - 09/2004
2	CytokinesIBA 05/2015 - 03/2004
2	Matrix Metalloproteinases (MMPs)IBA 05/2015 - 10/2003
2	Claudin-1IBA 03/2015 - 09/2012
2	EnzymesIBA 09/2012 - 04/2002
2	AntigensIBA 09/2012 - 04/2002
2	CA-19-9 Antigen (CA 19-9 Antigen)IBA 03/2008 - 09/2004
2	Dual-Specificity PhosphatasesIBA 04/2006 - 10/2003
2	Chemokine CXCL12IBA 02/2005 - 03/2004
2	Complementary DNA (cDNA)IBA 09/2004 - 01/2003
2	GDPmannose 4,6-dehydrataseIBA 09/2004 - 04/2002
2	FucoseIBA 09/2004 - 04/2002
2	Interleukin-6 (Interleukin 6)IBA 03/2004 - 10/2003
2	Chemotactic FactorsIBA 10/2003 - 04/2002
1	Biological ProductsIBA 01/2021
1	Fructose-Bisphosphate Aldolase (Aldolase)IBA 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	ProteomeIBA 01/2020
1	GangliosidesIBA 01/2020
1	GD3 ganglioside (GD(3))IBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Dinoprostone (PGE2)FDA Link 01/2020
1	EicosanoidsIBA 01/2020
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2020
1	12-Hydroxy-5,8,10,14-eicosatetraenoic AcidIBA 01/2020
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2019
1	matrigelIBA 01/2018
1	Cystatin CIBA 01/2018
1	Transforming Growth Factors (Transforming Growth Factor)IBA 09/2017
1	Methoxychlor (Metox)IBA 01/2017
1	Hemoglobins (Hemoglobin)IBA 01/2017
1	HexokinaseIBA 03/2016
1	Long Noncoding RNAIBA 10/2015
1	Untranslated RNA (Noncoding RNA)IBA 10/2015
1	Adapalene (Differin)FDA LinkGeneric 05/2015
1	VemurafenibIBA 05/2015
1	Interleukin-23 (Interleukin 23)IBA 05/2015
1	Neutralizing AntibodiesIBA 05/2015
1	DNA (Deoxyribonucleic Acid)IBA 02/2015
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 09/2012
1	ProstaglandinsIBA 09/2012
1	Cysteine-Rich Protein 61IBA 09/2012
1	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 09/2012
1	CX3C Chemokine Receptor 1IBA 01/2009
1	A-Form DNA (A-DNA)IBA 10/2008
1	HMGB1 Protein (HMG1)IBA 10/2008
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2007
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 04/2006
1	Phosphotransferases (Kinase)IBA 04/2006
1	NitrogenIBA 04/2006
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 04/2006
1	AntibodiesIBA 02/2005
1	CXC ChemokinesIBA 02/2005
1	CXCR4 Receptors (CXCR4 Receptor)IBA 03/2004
1	Messenger RNA (mRNA)IBA 10/2003
1	Mitogen-Activated Protein KinasesIBA 10/2003
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2003
1	Antisense OligonucleotidesIBA 04/2002

Therapy/Procedure

6	Therapeutics 01/2020 - 08/2008
1	Precision Medicine 01/2017
1	Low-Level Light Therapy (LLLT) 01/2014
1	Remission Induction 01/2003